[PMH2] Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia

[PMH2] Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia

2014 Value in health

Amri, I. | Millier, A. | Toumi, M. | Volume: 17, Issue: 7, Pages: A765-A766, Schizophrenia, Value,

Minimum Clinically Important Difference (MCID) can aid to assess the quality of improvement in functioning assessed by the Global Assessment Functioning (GAF). This scale, ranging between 0 and 100, subjectively rates the social, occupational, and psychological functioning of adults. The objective of this study was to generate MCID for GAF, based on a longitudinal cohort of patients with schizophrenia.

https://www.doi.org/10.1016/j.jval.2014.08.285; 10.1016/j.jval.2014.08.285